U.S. Senate Convenes Historic Roundtable on Aging Research

Global Coalition on Aging Leads Call to Action for Federal Research Priorities

WASHINGTON, DC (October 31, 2013) — Global Coalition on Aging (GCOA) Executive Director Michael W. Hodin, PhD, led a discussion with  the U.S. Senate Special Committee on Aging’s Members’ Roundtable on the nation’s most pressing needs around aging demographics. The October 29 roundtable was called by Committee Chairman Bill Nelson (D-FL) and included a diverse panel of leading medical and scientific experts on aging and the explosion of non-communicable diseases (NCDs), which increase with age.

“For the first time, our country is reevaluating and resetting its priorities for national research, which is leading to a massive shift in how we fund NCD research in order to give us a healthier and more active aging,” said Hodin. “How we fund aging research is our biggest fiscal challenge and economic opportunity. If we can bend the curve on diseases that strike us as we age – Alzheimer’s disease, diabetes, cancer, cardiovascular disease – and those physical capabilities that deteriorate as we age – our skin, vision, muscle capacity – we will transform how we live.”

Expert testimony from each of the panelists established the case not only for funding to enhance U.S. scientific competitiveness, but also for developing more coordinated research strategies across all sectors to better understand, address and cure NCDs.  According to the Gerontological Society of America, today less than one percent of the National Institutes of Health annual budget funds research into the underlying biology of aging and its role in the onset of disease.

Increased longevity, while challenging, also presents incredible opportunity. “The opportunity of population aging can be achieved through smarter spending on our health today,” said Hodin. “To truly change the paradigm of aging from one automatically associated with disease and disability to a healthier and happier process, we must view this spending as an investment – as we did in our spending on the space program, the interstate highway system and our nation’s children.”

“Medical research on ways to improve the health of our nation’s aging population should be a top priority. The need to increase collaboration among researchers has never been more important,” said Sen. Nelson during the roundtable.  Citing recently reduced research budgets due to sequestration, he noted the critical nature of the NIH to “our nation’s fiscal and physical health.”

Currently, a National Institutes of Health (NIH) initiative is underway aimed at achieving four goals:

  1. Increasing collaboration across institutes involved in aging research;
  2. Uncovering how similar cross-cutting collaboration is beginning to occur in the university setting and in the private sector;
  3. Highlighting scientific areas where an aging-oriented approach to ameliorating disease is promising and where disease-specific research is beneficial; and
  4. Enabling a better understand of how delaying or preventing age-related chronic diseases can help bend the health care cost curve.

The roundtable preceded and helped inform the October 30-November 1 NIH Geroscience Interest Group (GSIG) Summit titled “Advances in Geroscience: Impact on Healthspan and Chronic Disease.” The summit welcomes 500 scientists from academic research centers from around the country.

The GSIG is a recently formed group focused on “geroscience,” the study of the relationship between aging and age-related disease and disability and is among the largest trans-NIH interest groups. The summit was opened by Dr. Francis Collins, Director of the NIH.

GCOA applauds the Senate Special Committee on Aging for holding the roundtable, in particular Sen. Nelson, Ranking Member Susan Collins (R-ME), Sen. Elizabeth Warren (D-MA), and Sen. Joe Donnelly (D-IN).  We also congratulate the NIH, the Alliance for Aging Research and the Gerontological Society of America for leading the GSIG summit.

The roundtable participants were:

  • Richard Hodes, MD, Director, National Institute on Aging, National Institutes of Health
  • John Alam, MD, Head, Therapeutic Strategic Area for Diseases of Aging, Sanofi-Aventis
  • James Kirkland, MD, PhD, Professor, Noaber Foundation Professor of Aging Research and Director, Robert and Arlene Kogod Center on Aging, Mayo Clinic
  • Richard Morimoto, PhD, Professor, Department of Molecular Biosciences and Director, Rice Institute for Biomedical Research, Northwestern University
  • David Morgan, PhD, Chief Executive Officer and Director, Byrd Alzheimer Institute and Director of Neuroscience Research, University of South Florida College of Medicine

For more information about the roundtable, click here for the Committee’s website.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

A Bipartisan Bill Could Prevent The Next Pandemic

In Washington, Republicans and Democrats are typically at loggerheads when it comes to healthcare policy. Just consider the recent Inflation Reduction Act, which made extensive changes to Medicare and also extended Affordable Care Act subsidies. Every single congressional Democrat voted for the legislation, while every single member of the GOP voted against it. But occasionally, a bill is such an obviously good idea, and so desperately needed, that it commands significant bipartisan support. The PASTEUR Act, co-sponsored by 31 Democrats and 31 Republicans in the House and two members of each party in the Senate, is just such a bill.

Korea Must Act Now to Combat Growing AMR Threat

Public officials are overlooking one of the gravest long-term threats to the Korean people, the health system, and economy: antimicrobial resistance (AMR). Some pathogens ― bacteria, fungi, parasites, and viruses ― have evolved strains that resist the antimicrobial medications we currently have available to fight them. Health care professionals often must watch helplessly as patients succumb to infections that antibiotics could once have easily beaten. They know that new antimicrobials, including and especially antibiotics, could easily gain the victory ― but they have none at their disposal.

Policy Statement on the Impact of Price Negotiations on Innovation, Healthy Aging and Equity

As the CEO of the Global Coalition on Aging (GCOA) and a newly formed cross-sector Alliance for Health Innovation, we write to express our deep concern with the current legislation that allows for price “negotiations” in Medicare – a thinly veiled signal for America’s plunge into price controls that will have a devastating and adverse impact on biopharmaceutical innovation and our nations’ ability to support healthy aging. 

Ignoring the ‘Silver Economy’ May Be Getting Costly for Brands

In an ad for Airbnb that premiered earlier this year, a couple checks into a cozy Spanish villa. To the tune of Jay-Z's cover of "Me and My Girlfriend," the ad shows the pair settling into their rental and setting their collective dial to chill. They play ping-pong, sip some wine, and get ready for a night on the town. They're also in their 80s, celebrating their 57th wedding anniversary. In no way does the ad characterize the couple as elderly or portray them as needing special aid or services — they are just active people who happen to be old. It's a rare example of ads featuring a realistic depiction of aging.

Health Equity Promise and That Innovation Thing

President Biden has pledged his administration to defeat cancer, Alzheimer’s, and other diseases that target America’s aging population. To achieve these lofty goals, bold words must be backed up by bold actions.

Roundtable Report Highlights Importance of Immunizing Canada’s Caregivers Against Influenza, Identifying Challenges and Opportunities to Protect This Critical Group

The Global Coalition on Aging (GCOA) today released a report summarizing key insights from an expert roundtable on vaccinating Canada’s caregivers against influenza. The roundtable, held virtually, brought together leading Canadian health policy experts, family caregivers, patient advocacy groups, aging experts, and other thought leaders to discuss challenges and strategies to reach this critically important yet hard-to-reach group.